Volume 10, Number 6—June 2004
Books and Media
Quinolone Antimicrobial Agents, 3rd Edition
Highlight and copy the desired format.
|EID||Anderson GJ. Quinolone Antimicrobial Agents, 3rd Edition. Emerg Infect Dis. 2004;10(6):1177. https://dx.doi.org/10.3201/eid1006.040025|
|AMA||Anderson GJ. Quinolone Antimicrobial Agents, 3rd Edition. Emerging Infectious Diseases. 2004;10(6):1177. doi:10.3201/eid1006.040025.|
|APA||Anderson, G. J. (2004). Quinolone Antimicrobial Agents, 3rd Edition. Emerging Infectious Diseases, 10(6), 1177. https://dx.doi.org/10.3201/eid1006.040025.|
American Society of Microbiology Press,
Washington, DC 20036, USA
Pages: 485, Price: $125.95
The quinolone class is one of the more important classes of antimicrobial agents discovered in recent years and one of the most widely used classes of antimicrobial drugs in clinical medicine. Their broad spectrum of activity and pharmacokinetic properties make the quinolone agents ideal for treating a variety of infections. Their clinical importance is further demonstrated by their activity against a wide range of diseases of public health importance such as anthrax, tuberculosis, bacterial pneumonia, and sexually transmitted diseases.
Recent research has provided new data on the agent’s structure-function relationships, modes of action, resistance, pharmacokinetics, and drug interactions. The third edition of Quinolone Antimicrobial Agents nicely addresses these advances. The book is organized into four sections, each containing chapters written by leading experts.
Mechanisms and Spectrum of Activity and Resistance, the first major section, explores the basic biology of the quinolone class. The interrelationships between structure, antimicrobial activity, and side effects associated with various side chain positions of the quinolone are discussed here. Pertinent information on the bacterial topoisomerases and DNA gyrases, quinolone binding, DNA/RNA synthesis inhibition, cell death in the absence of protein synthesis, specific mutations within the quinolone resistance–determining region, and mutations that lead to altered access to target enzymes (efflux systems) is also highlighted.
In the next section, Pharmacology, the intricate field of quinolone pharmacokinetics (PK) and pharmacodynamics (PD) is evaluated. Information regarding absorption, distribution, metabolism, and excretion in a range of patient types is provided, followed by data gathered from pharmacokinetic/pharmacodynamic studies in a variety of models. This section also provides a review of the role of pharmacologic evaluation in optimizing therapy. The last two sections of the book, Clinical Applications and Adverse and Other Effects, will be of particular interest to clinicians. The chapters in this section include a comprehensive reference on general considerations, antimicrobial aspects, treatment models, clinical and comparative studies, and suggested treatment regimens for a host of infections. The chapter on adverse effects has been greatly expanded from the second edition because a substantial body of new information has since been gathered. Topics covered here include allergic reactions, effects on connective tissue structures and pregnancy, phototoxicity, and central nervous system and immune system toxicity.
The organization and content of this text make it a superlative reference. The discussions on treatments and adverse effects contain some of the most current data available. The field of antimicrobial resistance, however, is one of the most rapidly evolving areas with constant discoveries of new cases and data. Users should understand that while this text serves as a valuable reference, other sources should be consulted to ensure that the most comprehensive data are obtained. The references provided throughout, however, give the reader starting points to other literature.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Address for correspondence: Gregory J. Anderson, Centers for Disease Control and Prevention, Mailstop C12, 1600 Clifton Road, Atlanta, GA 30333, USA; fax: 404-639-4197
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 22, 2011
- Page last updated: February 22, 2011
- Page last reviewed: February 22, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)